by Robert Hayes Posted on October 6, 2019October 6, 2019 Wilmington’s Charles River Labs Joins Dementia Consortium, Reaffirms Commitment To Neuroscience Research Read More
by Robert Hayes Posted on October 1, 2019October 1, 2019 BUSINESS BRIEF: Wilmington’s Charles River Labs Adds Virginia Wilson To Board Of Directors Read More
by Robert Hayes Posted on April 30, 2019April 30, 2019 BUSINESS BRIEF: Wilmington’s Charles River Laboratories Completes the Acquisition of Citoxlab Read More
by Robert Hayes Posted on April 10, 2019April 10, 2019 BUSINESS BRIEF: Wilmington’s Charles River Labs & CHDI Foundation Extend Huntington’s Disease Collaboration Read More
by Robert Hayes Posted on February 16, 2019February 16, 2019 BUSINESS BRIEF: Wilmington’s Charles River Labs Signs Binding Offer to Acquire Citoxlab Read More
by Robert Hayes Posted on January 17, 2019January 17, 2019 BUSINESS BRIEF: Wilmington’s Charles River Labs Recognized For Advancing Gender Diversity In The Workplace Read More
by Robert Hayes Posted on January 11, 2019January 11, 2019 BUSINESS BRIEF: Wilmington’s Charles River Labs & Atomwise Form Strategic Alliance Read More
by Robert Hayes Posted on October 16, 2018October 16, 2018 Wilmington’s Charles River Labs Awarded $95.7 Million Contract By National Institute Of Allergy & Infectious Diseases Read More
by Robert Hayes Posted on May 6, 2018May 7, 2018 Wilmington’s Charles River Labs Announces Extended Relationship With Michael J. Fox Foundation Read More
by Robert Hayes Posted on March 10, 2018March 10, 2018 Wilmington’s Charles River Labs Makes Expansions to Global Biologics Infrastructure Read More
by Robert Hayes Posted on February 13, 2018February 13, 2018 Wilmington’s Charles River Laboratories To Acquire MPI Research Read More
You must be logged in to post a comment.